A detailed history of Aquatic Capital Management LLC transactions in Mannkind Corp stock. As of the latest transaction made, Aquatic Capital Management LLC holds 161,800 shares of MNKD stock, worth $1.14 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
161,800
Holding current value
$1.14 Million
% of portfolio
0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.01 - $6.7 $810,618 - $1.08 Million
161,800 New
161,800 $1.02 Million
Q1 2024

May 15, 2024

SELL
$3.25 - $5.27 $46,150 - $74,834
-14,200 Reduced 96.6%
500 $2,000
Q4 2023

Feb 14, 2024

BUY
$3.34 - $4.29 $28,724 - $36,894
8,600 Added 140.98%
14,700 $54,000
Q3 2023

Nov 14, 2023

SELL
$3.91 - $5.45 $89,930 - $125,350
-23,000 Reduced 79.04%
6,100 $25,000
Q2 2023

Aug 14, 2023

SELL
$3.72 - $4.79 $143,220 - $184,415
-38,500 Reduced 56.95%
29,100 $118,000
Q1 2023

May 15, 2023

BUY
$3.95 - $5.63 $267,020 - $380,588
67,600 New
67,600 $277,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.81B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.